Use of the Charlson combined comorbidity index to predict postradiotherapy quality of life for prostate cancer patients.
Wahlgren
Thomas
T
Department of Oncology-Pathology, Karolinska University Hospital and Institutet, Stockholm, Sweden. thomas.wahlgren@telia.com
Levitt
Seymour
S
Kowalski
Jan
J
Nilsson
Sten
S
Brandberg
Yvonne
Y